Literature DB >> 20167210

Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion.

Qi Lin1, Jian Hai, Li-Yun Yao, Yang Lu.   

Abstract

The neuroprotective effects of N-stearoyl-L-tyrosine (NSTyr) on cognitive function and neuronal plasticity during chronic cerebral hypoperfusion (CCH) in rats were investigated. After induction of CCH, NSTyr was administered daily for 3 months intraperitoneally. Cognitive functions were evaluated by Morris water maze and hippocampal long-term potentiation (LTP). Neuropathological changes were examined using light micrograph and Fluoro-Jade B staining. Neuronal plasticity was assessed by measuring the expression of MAP-2, GAP-43 and synaptophysin on hippocampal regions of rats with immunohistochemistry and western blotting. CCH resulted in significant spatial memory impairment and inhibition of LTP, and led to neurodegeneration in the CA1 region of the hippocampus in the model rats compared with the sham-operated rats. In the model rats treated with NSTyr, cognitive function improved. The expression levels of MAP-2 and synaptophysin protein in hippocampal areas in the model rats were less than those in the sham-operated rats, and increased in the model rats treated with NSTyr. However, no statistical significance of GAP-43 expression among the sham, model and NSTyr groups was observed. These data indicate that NSTyr exerts protective effects on cognitive function of rats after CCH, which may be related to the changes of neurodegeneration and neuronal plasticity in the hippocampal area of rats. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167210     DOI: 10.1016/j.brainres.2010.02.037

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Age-related difference in protective effect of early post-conditioning on ischemic brain injury: possible involvement of MAP-2/Synaptophysin role.

Authors:  Hedayat Samandari; Fatemeh Nabavizadeh; Ghorbangol Ashabi
Journal:  Metab Brain Dis       Date:  2019-08-30       Impact factor: 3.584

2.  Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.

Authors:  Shao-Hua Su; Yi-Fang Wu; Qi Lin; Jian Hai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-19       Impact factor: 3.000

3.  Acupuncture Rescues Cognitive Impairment and Upregulates Dopamine-β-Hydroxylase Expression in Chronic Cerebral Hypoperfusion Rats.

Authors:  Ling-Yong Xiao; Jing-Wen Yang; Xue-Rui Wang; Yang Ye; Na-Na Yang; Chao-Qun Yan; Cun-Zhi Liu
Journal:  Biomed Res Int       Date:  2018-07-12       Impact factor: 3.411

4.  Xiaoshuan enteric-coated capsule alleviates cognitive impairment by enhancing hippocampal glucose metabolism, hemodynamics and neuroplasticity of rat with chronic cerebral hypoperfusion.

Authors:  Man-Zhong Li; Yi Zhang; Hai-Yan Zou; Ya-Li Wang; Brian-Chi Yan Cheng; Lei Wang; Qiu-Xia Zhang; Jian-Feng Lei; Hui Zhao
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

Review 5.  Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome.

Authors:  María I Herrera; Lucas D Udovin; Nicolás Toro-Urrego; Carlos F Kusnier; Juan P Luaces; Matilde Otero-Losada; Francisco Capani
Journal:  Front Neurosci       Date:  2018-05-31       Impact factor: 4.677

6.  Deltonin Ameliorates Cerebral Ischemia/Reperfusion Injury in Correlation with Modulation of Autophagy and Inflammation.

Authors:  Yi Zhang; Zhiming Tian; Hongyan Wan; Wen Liu; Fanping Kong; Guoping Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-31       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.